The stock price of Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) has plunged by -2.47 when compared to previous closing price of 21.47, but the company has
In the past week, ARWR stock has gone down by -2.84%, with a monthly decline of -10.09% and a quarterly plunge of -7.88%. The volatility
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR)’s stock price has gone decline by -0.04 in comparison to its previous close of 23.94, however, the company has experienced
The stock of Arrowhead Pharmaceuticals Inc. (ARWR) has gone up by 11.19% for the week, with a -12.30% drop in the past month and a
Additionally, the 36-month beta value for ARWR is 1.00. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 1
Additionally, the 36-month beta value for ARWR is 1.00. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 1
The stock of Arrowhead Pharmaceuticals Inc. (ARWR) has seen a -4.40% decrease in the past week, with a 9.70% gain in the past month, and
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) has seen a rise in its stock price by 0.10 in relation to its previous close of 28.91. However, the
© 2024, Powered by Smart TechOne
